Education and training events
Advanced education and training of researchers are essential for the 3Rs. FIN3R organises training and education events on 3Rs. Further it also takes part in organizing other courses and doctoral training in cooperation with universities’ doctoral schools.
The Finnish 3R Centre and the Animal Welfare Body of Oulu Laboratory Animal Centre organises three joint webinars in November. Save the dates
Registration and links to the webinars:
FIN3R and OULAC joint webinar series 1 - 10/11/2022:
Animal-centric care and management – the importance of handling and training
Dr. Dorte Bratbo Sørensen, University of Copenhagen, Denmark
FIN3R and OULAC joint webinar series 2 - 17/11/2022:
Applied operant animal training in the lab – challenges and benefits
Dr. Dorte Bratbo Sørensen, University of Copenhagen, Denmark
FIN3R and OULAC joint webinar series 3 - 29/11/2022:
The influence of age on experimental outcomes and animal care
Dr. Paul Potter, Oxford Brookes University, UK
Congresses and Symposia
Three Rs symposium on 7.-8. Dec, 2022: Improving the quality and translatability of biomedical research through 3R principles
Registration is open (see link below)! No registration fee.
The objective of this symposium is to give an overview and examples of the current state-of-the-art in fundamental biological and pharmacological research and drug development, with a focus on scientific excellence, research quality, communication and Three Rs in relation to using laboratory animals. The symposium is organized by the University of Helsinki Doctoral Programme in Drug Research and the Finnish 3R Center.
Join us to learn and discuss about recent developments in the field of Three Rs, good research practice and communication in animal research!
Also - workshop on power analysis and session on disease modelling!
Find out more and register at the link below:
Universities organise regular education and training for competence for people working with experimental animals. The courses are harmonized throughout Finland, and they cover procedures on animals and project design. Course information is available on the websites of the host universities, or their laboratory animal centres.
Education and Training Platform for Laboratory Animal Science, www.etplas.eu, https://etplas.eu/learn/
EU-10: Design of procedures and projects – level 1, https://etplas.eu/learn/eu-10-experimental-design/
EU-11: Design of procedures and projects – level 2, https://etplas.eu/learn/eu-11-1-design-of-procedures-and-projects/
EU-12: The severity assessment framework, https://etplas.eu/learn/eu-12-the-severity-assessment-framwork/
Eu-25: Project evaluation, https://etplas.eu/learn/eu-25-2-project-evaluation/
EU-52: Searching for (existing) non-animal alternatives, www.etplas.eu/learn/eu-52/
EU-60: Developing in vitro methods and approaches for scientific and regulatory use, www.etplas.eu/learn/eu-60/
Webinars and seminars
- CPD LAS Webinars /Karolinska Institutet: “Proactive actions from industry to drive forward animal welfare, the 3Rs and science” will be presented by Dr. Kirsty Reid, Director Science Policy, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium.
Date: Tuesday, October 25, 2022 × Stockholm 1 PM CEST
The pharmaceutical industry is committed to the science-based phase-in of methods to replace the use of animals for scientific purposes and the deletion of animal tests which are obsolete or redundant. EFPIA members aim to lead progress on this by engaging in a wide range of practical activities to help drive the development, uptake and promotion of non-animal technologies (NATs) and new approach methodologies (NAMs) so that these can be phased-in as soon as it is scientifically possible to do so. There are a large number of initiatives underway within the pharma sector going beyond the legislative requirements for 3Rs. There are also a number of opportunities to join forces and drive this work forward on dialogue and collaborations. Dr Kirsty Reid will highlight some of these during the webinar session.
Dr. Kirsty Reid is team leader and Science Policy topic lead at EFPIA, where her focus includes innovation policy implementation with particular focus on science and research matters. She has over 16 years experience in EU public and regulatory affairs covering various EU legislation and policy areas, working specifically on animal experimentation; alternatives to animal testing, and environment, health and safety issues.
Register here (by Oct 24, 9.00 am CEST)
The Impact of the Animals’ Lived Experience” will be presented by Jennifer L Lofgren, Global Head of Animal Welfare and Compliance, Novartis Institutes for BioMedical Research, U.S.
Date: Thursday, 3 November 2022 × Stockholm 2 PM CET
While details such as how much nesting material we place in a cage, how we pick up a mouse during cage change, or which analgesic we administer may be fleeting and minor to in-vivo staff, these decisions can result in significant and impactful changes in the lived experience of our laboratory rodents. These impacts are not only to the animals’ welfare but also to the research results they produce. While these refinements were once considered nice to have, but far from necessary, published studies have now established that reducing stress associated with suboptimal housing, handling, and post-procedural pain management are important steps to improving laboratory rodent quality of life and the quality and success of the biomedical research to which they contribute. In this lecture we will explore this literature and learn about the relative impact on a variety of research models of both providing and withholding appropriate enrichment, reducing handling stress, and effective analgesics.
Jennie Lofgren, DVM, MS, DACLAM, is Global Head of Animal Welfare and Compliance at Novartis Institutes for BioMedical Research. At Novartis, Dr. Lofgren has worked with the global Animal Welfare Compliance team to increase education and transparency about the need for and value of animals in research and increased 3Rs opportunities for internal and external animal studies.
Register here (by Nov 2, 16.00 CET)
Webinar on Safer and Sustainable Innovation Approach for More Sustainable Nanomaterials and Nano-enabled Products will be held on Thursday 3 November 2022 at 14:30-16:30 CET / 09:30-11:30 EDT.
The Safer and Sustainable Innovation Approach (SSIA) is an approach aiming to boost safer and sustainable innovations by integrating safety and sustainability at an early stage of the design phase of innovative materials, products, applications, and processes. SSIA combines the Safe-and-Sustainable-by-Design (SSbD), Regulatory Preparedness (RP), and Trusted Environment (TE) concepts to identify and minimise sustainability impacts along with potential health and environmental risks in the innovation process. SSIA relies on early dialogue between industry and regulators and is facilitated by a Trusted Environment. SSIA aims to anticipate the regulatory challenges posed by innovative nanomaterials, nano-enabled products, or other advanced materials by minimising the gap between technological innovations and the development of suitable risk assessment tools and frameworks.
The second focus event of the Austrian 3R Center "Severe Suffering in Animal Experiments and How to Refine" will be held on the 7th of November 2022.
Annually, the Austrian 3R Center coordinates its focus topics with the Federal Ministry of Education, Science and Research and this time the focus is on severe suffering in animal experiments.
Webinar “Do ‘euthanasia’ methods for laboratory rodents really give them a ‘good death’?” will be presented by Dr Huw Golledge BSc PhD, Chief Executive & Scientific Director, Universities Federation for Animal Welfare, Hertfordshire, U.K.
Date: Friday, 25 November 2022 × Stockholm 1 PM CET
Euthanasia means a ‘good death’. Most laboratory rodents are killed with Carbon Dioxide (CO2), a procedure which is often referred to as euthanasia. In this talk I will summarise the extensive evidence that CO2 negatively impacts animal welfare when used to end the life of rats or mice. This evidence shows that CO2, even in low concentrations causes fear or anxiety which cannot be avoided if it used to kill rodents. Therefore, CO2 cannot be considered a method which offers a ‘good death’ for these species, and, moreover, that it should be considered a harm and factored into harm-benefit analyses when it is used to kill experimental subjects. I will then compare current and potential practical alternative methods to consider whether any of these offer the potential of a good death.
Huw Golledge is Chief Executive and Scientific Director of the Universities Federation for Animal Welfare (UFAW) - an international charity dedicated to the promotion of Science in the Service of Animal Welfare. Prior to joining UFAW he was an animal welfare researcher at Newcastle University in the UK and was a member of the UK’s national Animals in Science Committee from 2013-2016.
Register here (by Nov 23, 16.00 CET)
- Uniting in Toxicology: The XVI International Congress of Toxicology, 18–22 September 2022 in Maastricht, The Netherlands. www.ict2022.com
- AALAS National Meeting, October 23–27, 2022, Louisville, Kentucky, USA. www.aalas.org...
- 21st International Congress of the European Society of Toxicology In Vitro (ESTIV), 21–25 November 2022 in Barcelona, Spain. www.estiv.org/congress2022